Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ryota Ushio
Observed name:
R. Ushio
Institution:
Kanagawa Cancer Center
Observed institutions:
Yokohama City University Medical Center,
Yokohama City University Hospital,
Kanagawa Cancer Center,
Yokohama City University
ORCID:
0000-0002-2473-0281
Observed ORCID:
0000-0002-2473-0281
OpenAlex ID:
A5085535615
Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients
2015
·
Nobuyuki Horita
, Masaki Yamamoto
, et al.
·
Scientific Reports
·
107
PDF
Diagnostic test accuracy of loop-mediated isothermal amplification assay for Mycobacterium tuberculosis: systematic review and meta-analysis
2016
·
Kenjiro Nagai
, Nobuyuki Horita
, et al.
·
Scientific Reports
·
96
PDF
Digital PCR assay detection of circulating Mycobacterium tuberculosis DNA in pulmonary tuberculosis patient plasma
2016
·
Ryota Ushio
, Masaki Yamamoto
, et al.
·
Tuberculosis
·
89
Diagnostic test accuracy of anti-glycopeptidolipid-core IgA antibodies for Mycobacterium avium complex pulmonary disease: systematic review and meta-analysis
2016
·
Yuji Shibata
, Nobuyuki Horita
, et al.
·
Scientific Reports
·
58
PDF
Amrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patients
2016
·
Nobuyuki Horita
, Masaki Yamamoto
, et al.
·
Scientific Reports
·
46
PDF
Real‐world efficacy of atezolizumab in non‐small cell lung cancer: A multicenter cohort study focused on performance status and retreatment after failure of anti‐ PD ‐1 antibody
2021
·
Naoki Furuya
, Makoto Nishino
, et al.
·
Thoracic Cancer
·
33
PDF
Sensitivity and specificity of Cobas TaqMan MTB real-time polymerase chain reaction for culture-proven Mycobacterium tuberculosis: meta-analysis of 26999 specimens from 17 Studies
2015
·
Nobuyuki Horita
, Masaki Yamamoto
, et al.
·
Scientific Reports
·
29
PDF
Detection of Mycobacterium tuberculosis-derived DNA in circulating cell-free DNA from a patient with disseminated infection using digital PCR
2017
·
Masaki Yamamoto
, Ryota Ushio
, et al.
·
International Journal of Infectious Diseases
·
28
PDF
Diagnostic test accuracy of antigenaemia assay for PCR-proven cytomegalovirus infection—systematic review and meta-analysis
2017
·
H. Eguchi
, N. Horita
, et al.
·
Clinical Microbiology and Infection
·
25
Reconsidering the Cutoff Value for Sensitive and Refractory Relapses in Extensive-Stage SCLC in the Era of Immunotherapy
2023
·
Masahiro Torasawa
, Hidehito Horinouchi
, et al.
·
Journal of Thoracic Oncology
·
22
PDF
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
2024
·
Naoya Nishioka
, Hisao Imai
, et al.
·
Targeted Oncology
·
21
PDF
Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
2022
·
Ryota Ushio
, Shuji Murakami
, et al.
·
Journal of Clinical Medicine
·
21
PDF
Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer
2021
·
Ryota Ushio
, Masaki Yamamoto
, et al.
·
Internal Medicine
·
15
PDF
Hepcidin exerts a negative immunological effect in pulmonary tuberculosis without HIV co-infection, prolonging the time to culture-negative
2019
·
Ken Tashiro
, Masaki Yamamoto
, et al.
·
International Journal of Infectious Diseases
·
13
The Platelet Count Can Predict In-hospital Death in HIV-negative Smear-positive Pulmonary Tuberculosis Inpatients
2018
·
Hideto Goto
, Nobuyuki Horita
, et al.
·
Internal Medicine
·
11
PDF
Factors for Predicting Outcomes among Non-HIV Patients with Pulmonary Tuberculosis
2017
·
Toshinori Tsukahara
, Nobuyuki Horita
, et al.
·
Internal Medicine
·
8
PDF
Phase II study of gedatolisib for small-cell lung cancer (SCLC) patients (pts) with genetic alterations in PI3K/AKT/mTOR pathway based on a large-scale nationwide genomic screening network in Japan (EAGLE-PAT/LC-SCRUM-Japan).
2020
·
Hibiki Udagawa
, Takaya Ikeda
, et al.
·
Journal of Clinical Oncology
·
7
Afatinib + bevacizumab combination therapy in EGFR ‐mutant NSCLC patients with osimertinib resistance: Protocol of an open‐label , phase II , multicenter, single‐arm trial
2020
·
Nobuaki Kobayashi
, Hisashi Hashimoto
, et al.
·
Thoracic Cancer
·
4
PDF
Clinical impact of targetable gene alterations on therapeutic outcomes in stage II/III locally advanced non-small cell lung cancer patients.
2020
·
Yoshitaka Zenke
, Shingo Matsumoto
, et al.
·
Journal of Clinical Oncology
·
3
An Autopsy Case Report of Malignant Pleural Mesothelioma with Deciduoid Features
2015
·
Ryota Ushio
, Masaki Yamamoto
, et al.
·
Internal Medicine
·
3
PDF
HbA1c level cannot predict the treatment outcome of smear-positive non-multi-drug-resistant HIV-negative pulmonary tuberculosis inpatients
2017
·
Ken Tashiro
, Nobuyuki Horita
, et al.
·
Scientific Reports
·
2
PDF
Reconsidering the cutoff between sensitive and refractory relapses in extensive-stage small cell lung cancer in the era of immunotherapy.
2023
·
Masahiro Torasawa
, Hidehito Horinouchi
, et al.
·
Journal of Clinical Oncology
PDF
P77-10 Efficacy of amrubicin after immuno-chemotherapy for extensive-stage small-cell lung cancer
2022
·
Ryota Ushio
, Haruhiro Saito
, et al.
·
Annals of Oncology
Effects of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors on Immune Checkpoints
2020
·
C. Kamimaki
, S. Teranishi
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Identification of Predictive Biomarkers for Immunotherapy with Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
2020
·
S. Kubo
, N. Kobayashi
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Show more works
View as search
Works count:
27
Citation count:
641
H-index:
13
I10-index:
15
Year
Topic
Type